Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection
Journal of Medical Microbiology · 09.04.2026 · 75 (4)
DOI: 10.1099/jmm.0.002153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 09.04.2026. Verfasst von Ziting Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, 48109, USA. Hauptthemen laut MEDLINE: Burkholderia Infections, Burkholderia cenocepacia, Persistent Infection. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation Therapeutics, Pharmaceutical Research and Manufacturers of America Foundation.
Abstract (Originalsprache)
Introduction
Burkholderia cenocepacia , a member of the Burkholderia cepacia complex (Bcc), causes severe, treatment-resistant lung infections in individuals with cystic fibrosis and chronic granulomatous disease. Hypothesis. We hypothesized that the C3HeB/FeJ mouse strain, characterized by impaired macrophage-mediated immunity, would be susceptible to persistent infection by clinical Bcc isolates.
Aim
To evaluate C3HeB/FeJ susceptibility to various Bcc isolates and characterize the macrophage-intrinsic responses and antibiotic susceptibility within this model. Methodology. C3HeB/FeJ and C57BL/6 mice were compared for susceptibility to pulmonary infection with B. cenocepacia AU0728 following intratracheal inoculation. Bacterial persistence and extrapulmonary dissemination were monitored for up to 42 days. Host immune responses were assessed through systemic leucocyte profiling and analysis of bone marrow–derived macrophage (BMDM) function, including intracellular bacterial control, cytokine production and time-resolved cell-death responses. Model breadth was evaluated using three additional clinical Bcc isolates. Finally, the in vivo efficacy of high-dose ceftazidime or meropenem was assessed against established pulmonary infection.
Results
C3HeB/FeJ mice sustained significantly higher pulmonary burdens of B. cenocepacia AU0728 than C57BL/6 mice, resulting in a stable, non-sterilizing infection with extrapulmonary dissemination lasting at least 42 days. In vitro , C3HeB/FeJ BMDMs supported higher intracellular bacterial loads and failed to mount effective IFN-γ–dependent intracellular control. Mixed-effects modelling of cell-death responses revealed that both strains initiated early apoptotic signalling following infection; however, this response was attenuated in C3HeB/FeJ macrophages and was not restored by IFN-γ pretreatment. In contrast, late-stage membrane permeabilization increased progressively over time and exhibited strain- and IFN-γ–dependent modulation at later stages of infection. Susceptibility was highly strain-specific: three additional clinical Bcc isolates were rapidly cleared from C3HeB/FeJ lungs. Treatment with ceftazidime or meropenem reduced established pulmonary bacterial burdens by ~1.4–1.5 log₁₀ c.f.u. but did not achieve sterilization.
Conclusion
These findings identify C3HeB/FeJ mice as a selectively susceptible host for sustained pulmonary infection by B. cenocepacia AU0728 and demonstrate that persistence in this model is strongly strain-dependent. Impaired macrophage-intrinsic IFN-γ–dependent control and stage-specific dysregulation of cell-death responses contribute to bacterial persistence. This immunocompetent mouse model provides a tractable platform for dissecting strain-level virulence mechanisms and for evaluating therapeutic strategies targeting chronic Bcc infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, 48109, USA.
- Present address: Department of Integrative Biology, University of California, Berkeley, CA, 94720, USA.
- Present address: Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, 55455, USA.
- Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Förderung
- Cystic Fibrosis Foundation Therapeutics
- Pharmaceutical Research and Manufacturers of America Foundation
Zitieren
APA
Chen, Z., Romero-Gonzalez, M., Maser, A., Leng, R., Caverly, L. J., Hershenson, M., & Brunaugh, A. D. (2026). Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection. Journal of Medical Microbiology, 75(4). https://doi.org/10.1099/jmm.0.002153
Vancouver
Chen Z, Romero-Gonzalez M, Maser A, Leng R, Caverly LJ, Hershenson M, et al. Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection. Journal of Medical Microbiology. 2026;75(4). doi:10.1099/jmm.0.002153
BibTeX
@article{Chen2026,
author = {Chen, Ziting and Romero-Gonzalez, Mariana and Maser, Andrea and Leng, Ruisi and Caverly, Lindsay J and Hershenson, Marc and Brunaugh, Ashlee D},
title = {Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection},
journal = {Journal of Medical Microbiology},
year = {2026},
volume = {75},
number = {4},
doi = {10.1099/jmm.0.002153}
}
EUVIMED